Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Nuvilex, Inc. (OTCQB – NVLX) is no one-trick pony. The Company’s live-cell encapsulation drug delivery platform has already demonstrated that it can significantly improve the efficacy and safety results in mid-stage clinical trial studies in patients in advanced stages of pancreatic cancer. But, as the development progresses, it is not inconceivable that the size of the market for platform reaches the tens of billions worldwide. 

Late last week, Governor Martin O’Malley made it official. Following a public bill-signing ceremony, the State of Maryland will now become the 19th state in the Union to approve a medical marijuana program.

Broader Medical Marijuana Research Forges Ahead

It is clear that FNRG is an underfollowed and relative unknown in the LED market. However, as the Company hits on some of what we believe could be nearly $100M in projects up for bid, the stock could quickly trade to the $9.00 level.

Following a review of FAB’s Libsyn subscriber numbers and Netflix’s (NASDAQ – NFLX) subscriber growth and valuation methodology we believe that a case can be made that FAB’s Libsyn division could be worth $150M or more.

Leveraging the historical mining successes in the region and on the site itself, ARX Gold Corporation (OTCBB: DUCP) appears poised to take advantage of one of the most attractive mining opportunities in the industry.